« Back
Home /
Fremanezumab

Fremanezumab

Item no.	HY-P99019-10mg
Manufacturer	MedChem Express
CASRN	1655501-53-3
Amount	10 mg
Category	Antibodies In Vivo Antibodies
Type	Biosimilars
Specific against	other
Purity	95.00
Citations	[1]Stephen D Silberstein, et al. Fremanezumab for the Preventive Treatment of Chronic Migraine. N Engl J Med. 2017 Nov 30;377(22):2113-2122.
Smiles	[Fremanezumab]
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	TEV-48125
Available
Product Description	Fremanezumab (TEV-48125) is a humanized IgG2a monoclonal antibody that selectively and potently binds to calcitonin gene-related peptide (CGRP). CGRP is a 37-amino acid neuropeptide involved in central and peripheral pathophysiological events of migraine. Fremanezumab has the potential for chronic migraine research[1].
StorageTemperature	Store at 4°C for 2 years, do not freeze
Shipping	Blue Ice
Manufacturers Applications	Neuroscience-Neuromodulation
MolecularWeight	148000
Clinical_Information	Launched
Manufacturers Research_Area	Neurological Disease
Solubility	H2O
Manufacturers Target	CGRP Receptor
Pathway	GPCR/G Protein; Neuronal Signaling
Manufacturers Product type	Inhibitory Antibodies

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10 mg

available

Request delivery time